Newron Pharmaceuticals
NWRN.SW
#8322
Rank
C$0.21 B
Marketcap
$11.26
Share price
-1.10%
Change (1 day)
71.97%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -C$25.04 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are C$10.01 Million. In 2023 the company made an earning of -C$25.04 Million, an increase over its 2022 earnings that were of -C$26.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-C$25.04 Million-4.45%
2022-C$26.21 Million11.19%
2021-C$23.57 Million-30.14%
2020-C$33.74 Million6.84%
2019-C$31.58 Million31.45%
2018-C$24.02 Million170.13%
2017-C$8.9 Million-60.23%
2016-C$22.36 Million-41.46%
2015-C$38.19 Million109.46%
2014-C$18.24 Million22.43%
2013-C$14.9 Million222.49%
2012-C$4.62 Million-60.49%
2011-C$11.69 Million-71%
2010-C$40.31 Million-17.37%
2009-C$48.78 Million52.58%
2008-C$31.97 Million41.24%
2007-C$22.64 Million-25.19%
2006-C$30.26 Million22.45%
2005-C$24.71 Million